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Mutations of the Shank3 gene have consistently been identified as a risk factor for 
Autism Spectrum Disorder, and are associated with neurological abnormalities 
indicative of neural connectivity issues. This project aimed to elucidate the functions 
of Shank3 protein in the growth cone during neural development. It was 
hypothesised that in dorsal root ganglia growth cones, Shank would colocalise with 
Homer1b/c (a protein that regulates intracellular calcium responses to BDNF), that 
siRNA-mediated knockdown of Shank3 protein would reduce Shank expression, and 
that Shank3 knockdown would abolish growth cone turning responses to BDNF. 
Shank and Homer appeared to colocalise in the growth cone. However, Shank3 
knockdown did not decrease protein expression, and cell culture issues required that 
turning assays be terminated. As such, this research infers a role of Shank protein in 
peripheral nervous development but is unable to clarify the specific implications of 
this for axon pathfinding. Directions for future research include addressing cell 
culture issues, and repeating knockdown and turning experiments on hippocampal 





Neurodevelopmental and Autism Spectrum Disorders 
Neurologically diverse individuals experience differences in social 
behaviour, physical development, and cognitive processing, that are atypical of 
ordinary development, and often associated with functional impairment. For 
instance, the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) 
(American Psychological Association, 2013) characterises Autism Spectrum 
Disorder (ASD) as a neurodevelopmental disorder, with diagnostic features 
including abnormalities during socialisation, and engagement in atypical and often 
ritualistic behaviour. Diagnoses encompasses wide variation in phenotypes and 
functional impairments (American Psychological Association, 2013), and are often 
comorbid with intellectual disability (ID) (Kaufman, Ayub & Vincent, 2010). 
Following a meta-analysis of European, Australasian, American and African 
pervasive developmental disorder (PDD) studies, Elsabbagh et al. (2012) estimated a 
global PDD prevalence rate of 62 per 10 000 people, and 17 per 10 000 people for 
ASD. 
As diagnosis is lifespan persistent (American Psychological Association, 
2013), adults with ASD often experience poor psychosocial outcomes. Howlin, 
Goode, Hutton and Rutter (2004) report reliance on unsatisfying or menial jobs and 
lack of independence (such reliance on family members for care, or need for 
supported living) that is more common in individuals with comorbid ID. Research 
into neurological and genetic causes of ASD is of strong clinical significance for 
understanding how and why neural circuitry differences manifest in these individuals 




Neurological Correlates of ASD 
Autism spectrum disorder has clear neurological correlates. Relative to 
typically-developing controls, children with ASD demonstrate abnormally rapid 
increases in overall brain size. Examination of the medical records of 99 infants aged 
2-5 years (40 with ASD, 9 with PDD, 51 normally-developing controls) showed 
ASD diagnosis was associated with smaller-than-average head circumference at 
birth, that increased to significantly larger-than-average head circumference at 6-14 
months (Courchesne, Carper & Akshoomoff, 2003). This appears to indicate an 
initial brain mass deficit that is followed by neural overgrowth in infancy 
(Courchesne et al., 2003). This finding appears to be robust and is supported by a 
magnetic resonance imaging (MRI) study, showing that ASD diagnosis in children 
aged 3-4 is associated with significant enlargements of the cerebrum, cerebellum, 
hippocampus, and amygdalae relative to controls (Sparks et al., 2002). Results of 
this study were consistent in children with both average and lower-than-average 
intellectual functioning, suggesting that increased neural mass is common 
neurological ASD symptom across diverse intellectual phenotypes (Sparks et al., 
2002). Increases in white matter mass have also been inferred in 7 children with 
ASD aged 1.8-3.3 years following diffusion tensor imaging (DTI) (Bashat et al., 
2007).  
The literature I reviewed suggests that neurological differences common to 
ASD are present at birth (Courchesne et al., 2003), so they may begin embryonically. 
Whilst these studies appear to suggest ASD is associated with an increase in the 
number of individual neurons and glia in the brain, they could also suggest a 
potential role of neuronal hyper-connectivity and functional changes in 




Genetic Causes of ASD and the Role of Shank 
Identifying genetic causes of ASD, and their impacts on neurodevelopment, 
is a priority in current ASD research. A study of monozygotic and dizygotic twins 
containing at least one autistic proband demonstrated that the likelihood of twins 
developing ASD or similar functional deficits increased with genetic similarity 
(Bailey et al., 1995). 
Mutations of the Shank gene family have consistently been implicated in 
epidemiological studies of ASD. First identified by Naisbitt et al. (1999) as a 
scaffold protein in the post-synaptic density of excitatory neurons, the Shank family 
comprises Shank1, Shank2, and Shank3 protein isoforms. Structural features of 
Shank proteins include a PDZ domain, proline-rich region, ankyrin-repeating 
domain, SH3 domain, and sterile alpha motif (SAM) domain, each of which may 
bind to and regulate the function of other proteins (Hayashi et al., 2009; Naisbitt et 
al., 1999; Sheng & Kim, 2000). Shank gene mutations are associated with diverse 
neurological phenotypes, which appear to be mediated according to the site and type 
of disruption, and the protein binding sites effected (Durand et al., 2011; Hamdan et 
al., 2011; LeBlond et al., 2014; Marshall et al., 2008; Monteiro & Feng, 2017).  
The functional impairments of Shank-mediated ASD diagnoses are 
particularly pronounced when the Shank3 gene is mutated or protein production is 
impaired (i.e., haploinsufficiency) (Durand et al., 2011; Hamdan et al., 2011; 
LeBlond et al., 2014; Marhsall et al., 2008; Monteiro & Feng, 2017). For instance, 
Shank3 truncating mutation has been identified in an individual with ID and delayed 
language acquisition in a gene sequencing study (Hamdan et al., 2011). Perhaps the 
most salient example of Shank3 mutation is Phelan-McDermid syndrome, (Phelan & 




22q13 on chromosome 22. This results in deletion of the entire Shank3 gene and 
endogenous knockout of Shank3 protein (Phelan & McDermid, 2009). Phelan-
McDermid syndrome diagnosis is often comorbid with and includes common 
symptoms to ASD, including language delay, abnormal social behaviour, and 
abnormalities in body development, as well as neurological symptoms such as 
seizures, headache, sleep disturbance, and changes in sensory perception (Phelan & 
McDermid, 2009).  
Behavioural and Neurological Consequences of Shank Mutation in Animal 
Studies 
Gene editing techniques allow the introduction of known mutations to animal 
genotypes, and examination of resulting behavioural and neurological phenotypes. 
For instance, transfection of silencing RNA (siRNA) inhibits protein translation from 
messenger RNA and leads to protein knockdown (Bargmann & Gilliam, 2013). 
Introduced Shank gene mutations are associated with autistic-like behavioural 
phenotypes in vivo, as well as abnormalities in neural transmission that appear to be 
specific to the isoform targeted. 
Using immunocytochemistry, Wu et al. (2017) showed that Shank protein 
localises in the presynaptic neuromuscular junction of drosophila brains. Following 
various Shank mutations, synaptogenesis in the larval calyx was reduced, but 
subsequently rescued by transfection of an unmutated Shank gene sequence. Relative 
to controls, Shank-mutant drosophila displayed impaired performance on climbing 
assays, T-mazes, and motor and learning tasks, that was subsequently restored 
following transfection of unmutated Shank. As such, behavioural and neurological 





Shank1 KO mice show deficits in vocalisation when isolated from mothers, 
and abnormal scent marking behaviour in response to female urine, indicative of 
ASD-like abnormalities in social communication (Wöhr, Roullet, Hung, Sheng & 
Crawley, 2011). 
Shank2 Mutation 
Schmeisser et al. (2012) created homozygous and heterozygous Shank2 
knockout (KO) mice. Homozygous mutants (lacking both copies of Shank2) were 
hyperactive, anxious, more likely to engage in repetitive behaviours (e.g., grooming), 
and showed social abnormality relative to controls. Golgi staining revealed reduced 
dendritic spine density in CA1 hippocampal cells of homozygous KO mice relative 
to controls. Homozygous KO was associated with upregulation of Shank3 protein 
throughout the striatum, hippocampus, and cortex, as well as significant upregulation 
of NMDAR subunit GluN1, and improved NMDA-mediated LTP in Shank2 KO 
mice. However, overall glutaminergic transmission was impaired, with reduced 
overall frequency of excitatory post-synaptic potentials (EPSPs). The increased 
abnormal behaviour and neuronal pathology in homozygous mutants indicates that 
haploinsufficiency of Shank2 protein is associated with greater functional deficits 
and neuronal pathology. 
Zaslavsky et al. (2012) demonstrated that induced pluripotent stem cells 
containing various ASD-associated Shank2 mutations demonstrated increased axonal 
branching and synaptogenesis compared to unmutated controls, and greater 
frequency of excitatory post-synaptic currents. This research suggests a potential role 





Zhou et al. (2019) used CRISP_R to introduce known ASD-associated 
Shank3 mutations in macaque embryos. Compared to age- and sex-matched controls, 
gene-edited macaques displayed ASD-like behaviours including increased sleep 
disturbance, reduced arm muscle strength, abnormal social behaviour, and 
engagement in repetitive behaviours such as excessive grooming. Neuroimaging 
methods including MRI showed reductions in grey matter in gene-edited macaques 
compared to controls, as well as reduced connectivity in the default mode network 
and thalamus, and greater connectivity in the somatosensory cortex. This indicates 
abnormalities in neural circuitry that may alter processing in the sensory system, 
which may be inferred to underlie ASD symptoms like auditory hypersensitivity 
(American Psychological Association, 2013). An effect of Shank mutation on 
abnormal sensory processing appears to be likely, as Shank 1, 2, and 3-deficient 
mice and rats demonstrate deficient nociception following sharp pain, heat pain, and 
chronic pain (Han et al., 2016; Miletic, Dumitrascu, Honstad, Micic & Miletic, 2010; 
Yoon et al., 2017). Following Shank3 KO in mice, deficits in pain-like behaviour 
have been associated with reduced activity in spinal cord neurons and deficient 
activation of heat-pain receptors (Han et al., 2016). 
Durand et al. (2012) transfected cultures of human embryonic kidney (HEK) 
and COS-7 (monkey kidney) cells with various Shank3 mutations observed in 
specific ASD patients. With regards to the actin cytoskeleton, wild type Shank3 
(Shank3WT) localised in the actin filaments of HEK cells, but Shank3 mutated 
isoforms did not. In a co-immunoprecipitation assay, over-expressing Shank3WT 
increased F Actin production. This suggests that Shank3 colocalises with and acts on 




overexpressing Shank3WT in hippocampal neurons increased dendritic spine 
formation and spine head size, whereas hippocampal cells transfected with GFP-
tagged Shank3 mutations had reduced amplitude and frequency of excitatory post 
synaptic potentials compared to controls.  
In a study of neural correlates of Shank3 haploinsufficiency, Bozdagi et al. 
(2010) created heterozygous mutant mice lacking the ankyrin-repeating domain of 
the Shank3 protein. Shank3 haploinsufficiency was associated with deficient GluR1 
immunofluorescent puncta in immunohistochemical analysis of 3-4 month postnatal 
brain slices, indicating reduced number of synaptic AMPA receptors. In a patch-
clamp recording procedure of basal cellular activity, weaker EPSP activity was 
recorded in hippocampal CA1 neurons from mutant animals. At 2 hours post induced 
tetanus, LTP maintenance was impaired, and mutant cells failed to grow dendritic 
spines that would be necessary for functional connectivity in vivo. This suggests that 
Shank3 haploinsufficiency reduces synaptic formation of AMPA receptors, which in 
turn reduces electrical signalling and aberrations in cellular morphology. 
Furthermore, male Shank3 mutant mice displayed abnormal social behaviour 
including reduced anogenital and nose-to-nose sniffing of a female mouse compared 
to controls, and reduced ultrasonic vocalisation.  
Peça et al. (2011) created Shank3 mutant mice lacking PDZ domain binding 
sites. Shank3 mutant mice displayed abnormal social behaviour and increased 
anxiety in protocols like the open field test, as well as increased self-grooming, 
likelihood to experience seizures during routine handling, and self-injurious 
behaviour. Western Blot analysis showed reduced density of Homer1b/c and several 
glutaminergic proteins in striatal tissue of mutated mice compared to controls, 




Shank3 mutant mice also had increased caudate volume and reduced overall 
electrical activity in caudate-striatal tissue. 
The current literature is consistent with a narrative of Shank3 protein 
inducing LTP-based cellular morphological changes. Roussignol et al. (2005) 
demonstrated that pan-Shank protein was expressed in the dendritic spines of 
cultured hippocampal cells, and that small interfering RNA (siRNA)-mediated 
Shank3 knockdown reduced overall Shank immunoreactivity and was associated 
with decreased spine density. Furthermore, transfection of Shank3 led to dendritic 
spine growth in aspiny cerebellar granular cells, and was associated with increased 
density of ionotropic NMDA and AMPA receptors, greater mGluR1 
immunoreactivity, and greater NMDA- and AMPA-mediated basal electrical 
activity. It appears that Shank acts in tandem with Homer1 and metabotropic 
glutamate receptors to cause these changes, as transfection with Shank3 mutant 
plasmids lacking Homer1 and PSD-95 binding sites reduced localisation of pan-
Shank protein in spines, and reduced the number of mGluR1-reactive puncta.  
This literature indicates pan-Shank functions in the regulation of neural 
signalling, and supports the hypothesis that abnormalities in neural connection and 
synaptic transmission underlie autistic behaviour. In particular, Shank protein 
isoforms appear to work with Homer to regulate LTP, synaptogenesis, and 
glutaminergic signalling (Roussignol et al., 2005).  
The Role of Shank Protein in Embryonic Development 
The literature reviewed suggests a role of Shank gene in determining mature 
neuronal morphology and activity level, but there is currently a dearth of research 
into the potential role of Shank during synapse formation in embryo. This is 




and well documented, and have robust neurological and behavioural consequences in 
the literature reviewed. Secondly, the seminal study that identified Shank in the post-
synaptic density also found an unspecified Shank isoform in the growth cones of 
cultured hippocampal neurons (Naisbitt et al., 1999). Shank3 has since been 
identified in growth cones of cultured hippocampal neurons by Durand et al. (2012), 
within which neurons transfected with GFP-Shank3WT displayed greater growth cone 
motility than cells transfected with mutated Shank3. Thirdly, Shank binds to Homer 
at the proline-rich domain of mature neurons (Tu et al., 1999), a protein that 
regulates intracellular responses to excitatory neurotransmitters and is necessary for 
ordinary BDNF and Netrin-mediated cellular activity (Gasperini, Choi-Lundberg, 
Thompson, Mitchell & Foa, 2009). I therefore asked whether Shank3 regulates the 
circuit formation of embryonic neurons in vitro via intracellular signalling processes.  
Links to Homer 
Homer1 proteins comprise Homer1a and Homer 1b/c isoforms, all of which 
are capable of binding to IP3 and glutamate receptors (Tu et al., 1998). The crystal 
structure of Homer1a comprises an Ena/VASP homology 1 (EVH1) domain only 
(Hayashi et al., 2009), and is upregulated by neuronal excitation in the form of 
induced seizures (Brakeman et al., 1997). Homer1b/c isoforms contain an EVH1 and 
coiled-coil domain (Brakeman et al., 1997; Hayashi et al., 2009). Hayashi et al. 
(2009) demonstrated that Shank1 binds to Homer1b in the coiled-coil region, 
referred to this structure as a tetramer, and demonstrated that transfection of 
mutations to the Homer1b coiled-coil domain (to inhibit Shank1-Homer1b binding) 
was associated with reduced ability of CA1 hippocampal cells to form dendritic 
spines, and reduced NMDA- and AMPA-mediated excitatory post-synaptic current. 




dendritic morphology and electrical activity in vitro. It is possible that a regulatory 
role of Shank-Homer tetramers extends to other cell types that co-express Shank and 
Homer isoforms in vivo. 
The Growth Cone 
The growth cone is a structure on the distal tip of developing axons 
comprised of a central zone (containing microtubules) and a peripheral zone 
(containing filopodia and lamellopodia) (Zheng & Poo, 2007). Filopodia use 
chemoattractants and contact cues to guide cell motility, which is ultimately made 
possible by structural reorganisation of the growth cone (Zheng & Poo, 2007). Lin 
and Forscher (1993) used sea slug bag cell neurons as a model organism to 
demonstrate growth cone motility by fixing and staining cells at varying stages after 
cell-cell contact. Following filopodial contact cues, the growth cone moved its actin 
and organelles to the contact site to initiate turning. This was followed by turning of 
the two central zones, and movement of the microtubules from a fan-like complex to 
a set of parallel tubules at the contact site.  
Embryonic dorsal root ganglia (DRG) growth cones are excitatory pseudo-
unipolar cells of the peripheral nervous system (PNS). Cell cultures of embryonic 
Sprague-Dawley DRG were selected as the model cell type for this study, for two 
reasons. Firstly, embryonic DRG growth cones have consistent and well-documented 
attractive responses to neurotrophic factors including nerve growth factor (NGF) 
(Gundersen & Barrett, 1980) and brain-derived neurotrophic factor (BDNF) 
(Gasperini et al., 2009), and repulsive responses to semaphorin-3a (Pavez et al., 
2019; Gasperini et al., 2009; Mitchell, Gasperini, Small & Foa, 2012) and collapsin 
(Fan & Raper, 1995), and have been used within our laboratory to infer the effects of 




signalling (e.g. Pavez et al., 2019; Gasperini et al., 2009; Mitchell et al., 2012). Cell 
cultures of embryonic DRGs prepared within our laboratory typically develop axons 
with large, fan-like growth cones within 4-6 hours post-plating, allowing for motility 
assay experimentation within 1 day of dissection (see Mitchell et al., 2012).  
Secondly, Shank has previously been localised in mouse and rat DRGs in 
studies of protein haploinsufficiency and nociception. Miletic et al. (2010) describe 
upregulation of Shank1 protein in Sprague-Dawley rat DRGs following ligation of 
the sciatic nerve. Anisomycin injection (that inhibits translation of Shank1) was 
associated with decreased preferential weight-bearing in ligated animals, indicating 
decreased nociception. This means that Shank protein is present in the DRGs of 
mature rats, is necessary for sensory perception, and may therefore be present in 
embryonic DRG growth cones. Furthermore, extensive immunocytochemical 
analyses by Han et al. (2016) showed immunoreactive Shank3 protein in both pre- 
and post-synaptic areas of the spinal cord. The authors isolated Shank3 protein in the 
DRGs of mice, rats, and humans, and used patch-clamp recordings to identify 
deficient cellular responses to capsaicin (and associated reduced behavioural pain 
responses) in Shank3 knockout animals.  
The Effects of Glutamate and BDNF-binding on Intracellular Signalling  
Jessell and Sanes (2013) extensively reviewed the intracellular signalling 
pathways that occur following activation of metabotropic glutamate receptors 
(mGluRs) on the cell membrane. Following binding of glutamate to mGluR1, 
activated phospholipase C transforms phosphatidylinositol (4,5)-bisphosphate (PIP2) 
to diacylglycerol (DAG) and Inositol 1, 4, 5 triphosphate (IP3). Binding of IP3 to IP3 
receptors on the endoplasmic reticulum (ER) stimulates calcium release. Calcium-




then occurs, which has been implicated in attractive growth cone turning (Wen, 
Guirland, Ming & Zheng, 2004). Reichdart (2006) describes similar activation of 
Phospholipase C and resulting calcium release following binding of nerve growth 
factor (NGF) and brain derived neurotrophic factor (BDNF) to the Trk-A and Trk-B 
receptors, respectively. As such, neurotrophic factors including both glutamate and 
BDNF are implicated in a complex network of intracellular signalling that underlies 
calcium release. 
Mutated forms of Shank protein have the potential to disrupt BDNF-
mediated calcium release within the IP3 signalling pathway. Gasperini et al. (2009) 
demonstrated that Homer mediates ER-calcium release, and suggested that this 
occurs via Homer binding to TRPC channels on the ER membrane (demonstrated in 
Yuan et al., 2003). As such, Homer may potentially regulate both glutaminergic and 
BDNF-mediated calcium signalling through action on the IP3 signalling pathway. As 
Shank-Homer tetramers have been shown to be necessary for mature neuronal 
function (Hayashi et al., 2009; Tu et al., 1999) there is potential that disrupting 
Shank-Homer binding may also disrupt the ability of Homer to regulate IP3-mediated 
signalling. 
Calcium Regulates Growth Cone Motility 
Neuronal motility is calcium-dependent. Rises in intracellular calcium 
(whether via calcium influx through membrane receptors, or release from the 
endoplasmic reticulum (ER)) within a specific range encourage axonal extension, but 
fluctuations in calcium outside of this range inhibit outgrowth (Kater & Mills, 1991). 
Wen et al. (2004) state that this is because large intracellular calcium increases 
stimulate CaMK-II to facilitate attraction, whereas smaller increases activate 




Attractive and repulsive growth cone turning are disrupted following 
transfected knockdown of proteins that regulate ER-mediated calcium release. 
Gasperini et al. (2009) used live cell imaging techniques to demonstrate the effects 
of morphelino-mediated Homer1b/c knockdown on growth cone motility in DRGs. 
In a turning assay, Homer1b/c knockdown reversed the response to BDNF and 
Netrin-1 from growth cone attraction to repulsion, indicating disruption to 
intracellular signalling pathways. Follow-up calcium imaging revealed that calcium 
spikes were reduced in oligo-treated growth cones, an aforementioned cause of 
cellular repulsion (Kater & Mills, 1991). Application of thapsigargin was associated 
with ER-emptying in oligo-treated but not control cells that had previously been 
exposed to BDNF. This suggests that Homer1b/c knockdown inhibited BDNF-
induced ER-calcium release, and suggests that by regulating response to BDNF (and 
thus, calcium release), Homer1b/c regulates cell motility. Follow-up Western Blot 
and immunocytochemistry analysis showed that Homer1b/c colocalises with Stim1 
and TRPC, proteins that further regulate calcium release. 
Given that Shank has been localised in the growth cone (Naisbitt et al., 
1999), mutation of Shank is associated with deficits in neurological signalling, and 
Shank binds with Homer at the proline-rich domain in mature neurons (Hayashi et 
al., 2009; Tu et al., 1999), I asked whether Shank protein was involved in guiding 
growth cone motility via Homer1b/c. In a continuation of the work by Gasperini et 
al. (2009), it was hypothesised that Shank knockdown would disrupt BDNF-
mediated growth cone turning.  
Aims and Hypotheses 
Clarifying the neurodevelopmental role of Shank will shed light on whether 




resulting abnormal neural circuit formation. The aim of this research is to determine 
whether Shank3 protein haploinsufficiency leads to aberrant growth cone turning in 
response to BDNF, and whether this may be due to functional binding with 
Homer1b/c in the growth cone. For this study, there were three hypotheses, each of 
which corresponds to a specific experiment. 
Firstly, it was hypothesised that Shank and Homer 1b/c would colocalise 
within the growth cones of embryonic DRGs, as evidenced by overlaying 
immunoreactivity after immunostaining Shank and Homer with 594 and 647-tagged 
secondary antibodies, respectively. Given that Homer-Shank tetramers interact in 
vitro to regulate mature cell morphology and activity (Hayashi et al., 2009), 
colocalization in the growth cone may suggest protein-protein binding and 
interaction during neurodevelopment. 
Secondly, following siRNA-mediated Shank3 knockdown, 
immunocytochemistry analyses would demonstrate a significant decrease in overall 
Shank immunoreactivity in cell somas and growth cones, as compared to wild type 
(WT) control cells untreated by siRNA. Significant differences in immunoreactivity 
would be consistent across a minimum of 3 repetitions of the same knockdown 
experiment. 
Thirdly, growth cone turning response to BDNF would be significantly 
attenuated in growth cones derived from siRNA-treated cultures. It was hypothesised 
that during a 30-minute turning assay, WT control growth cones would grow 
towards a gradient of BDNF exuded from a micropipette placed 70 microns and 45 
degrees from the growth cone. In contrast, cells triturated with Shank3 siRNA were 




After testing these three hypotheses, it should be possible to infer whether 
Shank3 protein is involved in BDNF-dependent growth cone motility in vitro. The 
experiments conducted within this study also explore the possibility that Homer1b/c 






Materials and Methods 
Animals 
All procedures were carried out in accordance with National Health and 
Medical Research Council ethics guidelines following approval from the Tasmanian 
Animal Ethics Committee. At 18.5 days post-fertilisation (E18.5), pregnant Sprague-
Dawley rats (N = 25)  were euthanised via CO2 inhalation by a competent laboratory 
staff member, and checked for reflexes to ensure animals were deceased. Embryos 
(N = 58) were then removed and decapitated in a petri dish using sterile forceps.  
Cell Culture  
Embryos were kept on ice prior to dissection. Skin and spinal cords were 
removed from embryos using sterile forceps to reveal DRGs. These were then 
dissected into Earle’s Balanced Salt Solution (EBSS; Gibco) and placed in 200ul 
aliquots of Sensory Neuron Media (SNM). Cells were then triturated and plated 
directly onto coverslips, or left in 1ml SNM overnight at 5ºC. 
Transfection 
Shank3 knockdown was achieved by triturating cells 10-20 times in 200ul 
SNM with 2ul Shank3 siRNA (Thermo Fisher Scientific, Cat# s133190). Wild type 
(WT) cells were triturated without siRNA. Cells were then plated onto coverslips 
that had been nitric acid washed, pre-treated with polyornithine (PORN) (250ul 
10mg/ml PORN stock in 2250ul pure MilliQ water), UV cycled for 20 minutes, and 
coated with 50-100ul of 1mg/ml laminin solution (50ul laminin stock in 950ul 
Tris/NaCl). Cells were grown at 37ºC in a 95% air/5% CO2 humidified incubator for 





After >12 hours incubation, cells were fixed for a minimum of 10 minutes in 
4% paraformaldehyde solution (PFA) and then rinsed three times for 10 minutes 
using phosphate buffered solution (PBS; pH 7.5). Cells were blocked and 
permeabilised in a solution comprising 0.4% Triton-X-100 (Sigma-Aldritch) with 
5% Normal Goat Serum (NGS) or Sheep Serum (SS) in PBS. Primary antibodies for 
immunocytochemistry were anti-Homer 1b/c (rabbit, 1:200; Cat#160023, Synaptic 
Systems) and anti-PAN-Shank (mouse, 1:200; Cat#S23b-49, Gene Tex) diluted in 
PBS with 5% NGS or Sheep Serum. Coverslips were incubated in primary antibody 
solution at 5ºC overnight then rinsed with three PBS rinses. Secondary antibodies 
were Alexa fluor 647 anti-Rabbit (1:1000), Alexa fluor anti-mouse 568 (1:1000), 
Alexa Fluor anti-mouse 594 (1:1000), Alexa Fluor Phalloidin 488 (1:200), and 
Hoescht Staining Dye Solution (1:10000, Cat#33342), which were bath-applied to 
cells in a darkened box for two hours and diluted in a PBS solution with 5% NGS or 
SS. Secondary antibodies were then removed from coverslips, which were rinsed 
three times in PBS, air dried, and mounted in DPX (Sigma-Aldrich) on glass 
microscope slides. 
Live Cell Imaging 
Procedures for coverslip preparation and knockdown are as described above. 
Coverslips for growth cone turning were glued to plastic turning dishes and cells 
were plated in 200ul SNM, left to grow for 12 hours, then fed with 2ml SNM 
directly prior to turning. 
Chemoattractants used for turning were brain derived neurotrophic factor (BDNF) or 
control fluid (SNM). Live cell imaging was performed at 40x magnification on a 




growth cones, at a distance of 70nm. Turning videos were comprised of 260 frames, 
taken once every 7 seconds for 30 minutes. Videos were retained for image analysis 
if cells extended a minimum of 10 microns over 30 minutes and had uncollapsed 
growth cones with visible filopodia and lamellipodia.  
Microscopy 
Immunofluorescent images for Shank3 knockdown experiments were 
acquired on an Olympus BX50 microscope using a 60x water immersion lens. 
Coverslips were searched systematically (left to right, top to bottom) for DRGs with 
axons and growth cones. Immunofluorescence for green (F actin, 500ms light 
exposure), red (Shank, 500ms light exposure) and blue (nuclei, 10ms light exposure) 
channels was captured using NIS elements software and a CCD camera 
(Photometrics, USA). Individual cells were selected for analysis by identifying DRG 
nuclei by Dapi immunoreactivity, and then confirming pseudo-unipolar morphology 
with an F-actin stain. Images of cells with axons and growth cones were taken 
preferentially due to the focus of this project on the neuronal growth cone. In 
situations where coverslips did not contain cells with axons and growth cones, cells 
with a visible F-actin cytoskeleton and nucleus were captured for somatic Shank 
analysis. Images were saved as stack ND2 files on a server accessible to researchers 
within the molecular neurobiology laboratory. 
Immunofluorescent images for Shank and Homer immunocytochemistry 
were captured on a PE Spinning Disk microscope using channels FITC to identify F 
Actin fluorescence, TRITC to identify Homer1b/c, and CY5 to identify pan-Shank. 
Dorsal root ganglia soma and growth cones were identified as described above. Raw 




Image Analysis for Immunocytochemistry Experiments 
The image analysis program Fiji (NIH) was used to quantify colocalization of 
Homer1b/c and pan-Shank protein in the growth cone. Stack images were split 
according to colour channel, and stack images were flattened. Homer1b/c was 
labelled in red and pan-Shank and F Actin were relabelled in green and cyan, 
respectively. Merged red and green (with resultant yellow coloration) were 
interpreted as evidence of Homer1b/c and pan-Shank colocalization. 
Shank knockdown was quantified in the soma and growth cones of DRGs 
using Fiji. For knockdown analyses, stack images (16-bit) were split by colour 
channel and the red channel (Shank) was selected. Pixel intensity in the soma and 
growth cone was calculated by drawing around areas of interest, and measuring the 
integrated density of red immunoreactive pixels. In order to calculate differences in 
immunofluorescence between areas of protein fluorescence and areas of background, 
I analysed pixel density in cell soma (N = 30) and equivalent-sized sections of black 
background (N = 30) from WT (N = 30) cell images. This revealed that protein 
fluorescence was greater in soma (M = 7.53e+7, SD = 4.52e+7) than in background 
(M = 2.67e+7, SD = 1.97e+7). As such, reductions in Shank3 expression in the soma 
should be indicated by reduced integrated density measurements (i.e., more black 
background).  
Design and Statistical Analysis for Knockdown Experiments 
Shank3 knockdown experiments were comprised of two independent 
variables (IVs). The first IV, treatment group, had two levels: siRNA-mediated 
knockdown cells (KD) and wild-type cells (WT). Knockdown experiments were 




pregnant animals. As such, experiment number was included as a second IV with 
three levels: Experiment 1, Experiment 2, and Experiment 3. 
A 2 x 3 between subjects ANOVA was performed in Jamovi to analyse 
differences in somatic Shank immunoreactivity between KD and WT cells. A priori 
power analysis for 2 x 3 ANOVA was computed in G power, and indicated that a 
sample size of 27 items per condition (N=162) was required to find a moderate 
effect size at 80% power with alpha values set at .05. Although I originally planned 
to analyse growth cones with this method, soma were analysed because as cultures 
did not grow sufficient growth cones to power a 2 x 3 ANOVA.  
Design and Statistical Analysis for Turning Experiments 
All turning data calculations were performed in the image analysis program, 
Fiji (NIH). Turning angle (calculated with the angle tool) and extension (calculated 
with the line tool) were calculated in microns at two time points – in frame 1 (prior 
to chemoattractant exposure), and frame 260 (after 30 minutes of chemoattractant 
exposure). As such, independent variables were time (Frame 1, Frame 260), 
chemoattractant (BDNF, SNM control) and cell treatment group (KD, WT). 
Dependent variables were growth cone extension (microns) and turning angle 
(degrees). I therefore planned to analyse turning data in SPSS using MANOVA. A 
priori power calculation in G Power indicated that to achieve 80% power for a 2x2x2 






Shank and Homer 1b/c Colocalize in Dorsal Root Ganglia Growth Cones  
As Shank and Homer colocalize in mature neurons (Tu et al., 1999), and 
Homer1b/c has been identified as a regulator of ER-calcium release and growth cone 
motility (Gasperini et al., 2009), I hypothesised that Shank and Homer1b/c proteins 
would colocalise in DRG growth cones. Consistent with this hypothesis, merging 
green (Shank) and red (Homer1b/c) channels during image analysis was associated 
with a pattern of yellow coloration in merged images of the growth cone, indicating 
colocalization (see Figure 1E). Shank and Homer1b/c protein expression appears to 
be strongest in the axon and central region of the growth cone, with weaker 
immunoreactivity in filopodia and lamellopodia (See Figure 1A-D). However, this 
result should be interpreted with caution due to large amounts of red background in 
Homer1b/c staining.  
Interestingly, merging green (Shank) and cyan (F Actin) colour channels was 
associated with an aquamarine coloration pattern in merged images of the growth 
cone. This suggests that Shank colocalizes with F Actin in the central region of the 








Figure 1.(A) Colocalisation (yellow) of Shank (Green) and Homer1b/c (Red) protein in the dorsal root ganglia axon and growth cone (B-D) 
Dorsal root ganglia axon and growth cone expressing Homer 1b/c (Red), F Actin (Cyan), and pan-Shank (Green) protein. (E) Close up image of 
F Actin, Homer1b/c and pan-Shank expression in the growth cone, showing colocalization (yellow) of Shank and Homer1b/c. Filopodia 








Figure 2. (A) Image of DRG soma showing nucleus (blue), Shank protein (red), and F-Actin cytoskeleton (green).(C, E, G, I, K) Colocalization 
(yellow) of somatic pan-Shank protein and F Actin. (B, D, F, H, J, L) Somatic Pan-Shank protein in wild type and siRNA-treated dorsal root 




There was no Significant Effect of siRNA-mediated Shank3 Knockdown on 
Somatic pan-Shank Immunoreactivity 
In order to test the second hypothesis, Shank3 knockdown was quantified in 
DRG somas. Immunocytochemical stains revealed that pan-Shank protein was 
enriched in the soma of both siRNA-treated and control DRGs and appeared to 
colocalize with F Actin (see Figures 2C, 2E, 2G, 2I & 2K). Pan-Shank 
immunoreactivity appeared to be weaker in the nucleus (see Figure 2H, 2J, and 2L).  
Somatic knockdown of Shank3 protein was quantified using a 2 x 3 
ANOVA. Data screening was performed to verify that assumptions of ANOVA were 
met, including normality, independence of observations, and homogeneity of 
variance. Cells were nested in coverslips, which may have undermined 
independence. Levene’s test was non-significant, F (5, 156) = 2.15, p = .062, 
indicating the assumption of homogeneity of variance was not violated. The 
assumption of normality appeared to have been violated in raw data histograms (See 
Appendix 1). Therefore, raw integrated density scores were transformed using the 
natural logarithm function, and the ANOVA was performed on log scores. Following 
transformation, histograms revealed reductions in data skew and outliers indicating 
improved normality, and residuals approached normal distribution in a Q-Q plot. 
However, Levene’s test was significant, F (5, 156) = 4.43, p < .001, indicating 





 Table 1 
Descriptive Statistics for Somatic Pan-Shank Immunoreactivity in Knockdown and Wild Type Cells, prior to Log Transformation 
Treatment Group Experiment 
Number 









Knockdown (KD) 1 27 8.04e+7 8.12e+7 2.97e+7 6.31e+7, 9.77e+7 
 2 27 6.54e+7 5.40e+7 5.15e+7 4.81e+7, 8.28e+7 
 3 27 7.96e+7 8.63e+7 3.55e+7 6.23e+7, 9.70e+7 
 Overall 81 7.52e+7 7.34e+7 4.01e+7 6.51e+7, 8.52e+7 
Wild Type (WT) 1 27 6.90e+7 8.45e+7 3.76e+7 5.17e+7, 8.64e+7 
 2 27 7.02e+7 5.74e+7 5.78e+7 5.29e+7, 8.76e+7 
 3 27 6.87e+7 5.79e+7 5.41e+7 5.14e+7, 8.61e+7 
  Overall 81 6.93e+7 6.16e+7 5.00e+7 5.93e+7, 7.93e+7 
   Marginal Mean     
 1 54 7.47e+7 8.15e+7 3.40e+7 6.24e+7, 8.70e+7 
 2 54 6.78e+7 5.52e+7 5.43e+7 5.56e+7, 8.01e+7 






Log-transformed scores were analysed with a 2 x 3 ANOVA. Analysis of the 
main effect of treatment group revealed a small but nonsignificant increase in 
integrated pan-Shank pixel density in KD compared to WT cell somas, F (1, 156) = 
1.67, p = .080, η2p = .02. (See Table 1). The nonsignificant result means that pan-
Shank immunoreactivity in the cell soma was consistent across KD and WT 
treatment groups. 
There was a small but non-significant main effect of experiment number on 
pixel density, F (2, 156) = 2.48, p = .087, η2p = .03. (See Table 1). This means there 
were no significant differences in Shank immunoreactivity across the three 
repetitions of the experiment, meaning results were consistent. Due to the lack of 
significance, post-hoc tests were not performed.  
There was no significant interaction between experiment number and 
treatment group, F (2, 156) = 0.38, p =.337, η2p = <.01. This means that the non-
significant effect of siRNA treatment was consistent across all three experiments. 
There was no Significant Effect of Shank3 Knockdown on pan-Shank 
Expression in the Growth Gone 
In order to verify that non-significant knockdown effects were not soma-
specific, I performed follow-up analyses quantifying the effect of Shank3 
knockdown on pan-Shank immunoreactivity the growth cone. Of the 162 cells tested 
originally, 52 grew growth cones. Pan-Shank immunoreactivity was evident in both 
collapsed and uncollapsed growth cones across all three experiments and treatment 
groups (see Figure 3). 
I quantified the effects of Shank3 knockdown in KD and WT growth cones 
by calculating the integrated density of red immunoreactive pixels indicating 




that pan-Shank protein expression was consistent across the three experiments, 
treatment group (KD, WT) was included as the sole independent variable in this 
analysis.  
I planned to compare pan-Shank immunoreactivity in KD and WT control 
growth cones using an independent samples t test. However, assumption checks 
revealed data were not normally distributed, and this was not rectified using log 
transformations. Untransformed scores were therefore analysed using a non-
parametric Mann-Whitney U test with the hypothesis that integrated density of 
immunoreactive pixels would be unequal between WT and KD growth cones.  
A Mann-Whitney U test revealed that pan-Shank immunoreactivity was 
slightly increased in WT growth cones (N = 29, M = 7.43e + 6, SD = 6.75e + 6), as 
compared to KD growth cones (N = 25, M = 5.96e + 6, SD = 2.79e + 6), U (52) = 
357, p = .931, 95% CI [-2.83e - 6, 2.05e + 6], d = -.28. This represents a small-to-
medium effect that was not statistically significant. However, results may be 
underpowered and should be interpreted with caution. A priori power analysis was 
not possible due to the reliance of this analysis on previously collected data.  
The Effects of Shank3 Knockdown on Turning were not Quantifiable 
In order to test the effects of Shank3 knockdown on growth cone motility and 
extension, I planned to capture 120 live cell turning videos, and analyse these with a 
2 x 2 x 2 MANOVA. However, cell culture growth was insufficient to adequately 
power this analysis. Turning assays were attempted with KD and WT cell cultures on 
five separate sessions. Across all sessions, only 10 live cell videos (7 WT control) 
were captured. Of these, 4 were unsuitable for analysis due to collapsed growth cone 
morphology, failure of the growth cone to extend a minimum of 10 microns in 30 




required 3-6 hours, it was decided that the time commitment required for turning 








Figure 3.(A) Dorsal root ganglia with soma, nucleus (blue), axons, and growth cone expressing pan-Shank (red) protein and F actin (green). Pan-
Shank immunoreactivity in the growth cones of siRNA-treated and wild type dorsal root ganglia. (C, K) Uncollapsed growth cones showing 
colocalization (yellow) of Shank protein with F Actin. (E, G, I) Collapsed WT and siRNA-treated growth cones. (B, D, F, H, J, L) Expression of 




There was no Significant Difference between Knockdown and Wild Type Cell 
Culture Growth 
Failure to complete turning experiments was unexpected and necessitated re-
evaluation of cell culture methodology and identification of potential confounds. 
During live cell imaging and immunocytochemistry experiments, naïve observation 
suggested that siRNA-treated DRGs appeared to grow fewer axons, and were more 
prone to collapse compared to wild type controls. I therefore asked whether Shank3 
siRNA treatment reduced axonal growth. To test this hypothesis, and eliminate 
potential effects of my own inexperience on cell culture failure, a competent member 
of the laboratory group pre-prepared coverslips with WT DRG cell cultures (N=2), 
and cultures containing siRNA (N = 2). Using protocols described previously, I 
stained cultures for expression of F actin and nuclei. Microscopic analysis of growth 
cones was completed using a BX50 60x water lens. Due to the focus of this 
hypothesis on neural growth, only DRGs with a minimum of one axon were included 
for analysis (N=19). 
For this experiment, there was a single IV (cell treatment group) with two 
levels (KD, WT control), and a single DV (number of growth cones). Data were 
analysed in Jamovi with an independent sample t test, revealing that there was no 
significant effect of siRNA treatment on the number of growth cones displayed by a 
cell, t (17) = .16, p = .879, d = .07, 95% CI [ -.56, .65]. Wild type DRGs with growth 
cones (N = 10) grew a mean of 1.40 growth cones per cell (SD = .52), whereas KD 
DRGs with growth cones (N = 9) grew a mean of 1.44 growth cones per cell (SD 
= .73).  
During turning assays, I also observed that the majority of growth cones in 




motile growth cones should display a fan-like, spreading morphology for turning 
assays to be viable (see Figure 3 images KD1, WT1, and WT3). I therefore asked 
whether growth cone morphology (collapsed, uncollapsed, or contacting another 
cell) differed from a random distribution within the sample of 19 DRGs analysed 
above.  
A chi square goodness of fit test was used to examine the morphology of the 
first growth cone of every DRG (N = 19). Data were categorical and expected counts 
per cell were >5, meaning assumptions were met. Growth cone morphology types 
differed significantly from a random distribution, χ² (2) = 17.8, p <.001. Of the 
growth cones analysed, 15 were collapsed, two had made contact cues with other 
cells, and only two were uncollapsed and suitable for turning analysis.  
In order to determine whether growth cone viability for turning assays was 
compromised by siRNA-treatment, I asked whether growth cones derived from KD 
cultures were more prone to collapse than WT growth cones. However, a chi square 
test of independence revealed that morphology of the first growth cone was not 
dependent on treatment group, χ² (2) =.01, p =.993, Kramer’s V = .03. This means 







The aim of this study was to elucidate the function of Shank3 protein in the 
growth cone of developing DRG growth cones. It was hypothesised that knockdown 
of Shank3 would abolish turning in response to BDNF, a typically attractive 
neurotrophic factor. However, the current project was subject to ongoing cell culture 
issues that decreased the ability to elucidate functions of the Shank protein in vitro. 
As such, we did not find support for the alternative hypothesis that Shank3 
knockdown would disrupt BDNF-induced turning, but equally cannot reject the null. 
Pan Shank Protein is Present in the Growth Cones of Dorsal Root Ganglia and 
Colocalizes with Homer1b/c 
Consistent with the first hypothesis, Shank protein was localised in the 
growth cones of DRGs and colocalised with Homer1b/c. This finding is clinically 
significant for several reasons. 
Firstly, to my knowledge, the discovery of pan-Shank protein in the growth 
cones of DRGs is novel. Han et al. (2016) previously localised Shank3 protein in the 
DRG of rats, mice, and humans, and identified both pre- and post-synaptic functions 
of Shank3 in the spinal cord. Similarly, Miletic et al. (2010) implicated Shank1 in 
the regulation of pain signalling in mature DRGs. The current study suggests another 
role of Shank protein in the DRG, in embryonic axonal development. An unspecified 
Shank protein isoform (Naisbitt et al., 1999) and Shank3 protein (Durand et al., 
2011) have both previously been localised in the growth cones of cultured 
hippocampal neurons, indicating a role of this protein in central nervous 
development. However, to my knowledge, this is also the first study to localise 




What does this mean for our understanding of Shank protein function in 
ASD? Firstly, this suggests a role of Shank protein in peripheral axonal projection. 
Interestingly, haploinsufficiency of all three Shank isoforms has been implicated in 
ASD-like phenotypes and deficient nociception in rodents (Han et al., 2016; Miletic 
et al., 2010; Yoon et al., 2017). A common symptom of ASD is abnormal sensory 
perception (American Psychological Association, 2013). If future research shows 
Shank haploinsufficiency reduces growth cone responsiveness to attractive 
neurotrophic signals in peripheral neurons, this may indicate that abnormal 
perceptive features of ASD are due to inability of peripheral sensory neurons to find 
CNS targets. 
There is another potential implication of the current finding. I stained DRGs 
for pan-Shank immunoreactivity, and failed to confirm knockdown following 
treatment with Shank3 siRNA. As such, it is entirely possible that stains were 
reactive to Shank1 or Shank2 isoforms. The lack of Shank3 knockdown suggests that 
embryonic DRG development may involve Shank1 or Shank2 isoforms, whereas 
cellular signalling in mature DRGs appears to be regulated by Shank1 and Shank3 
(as shown in Han et al., 2016 & Miletic et al. 2010). As specific isoform staining 
would be required to validate this hypothesis, a clearly defined question suitable for 
a future thesis project would be: does Shank isoform expression differ between DRG 
cultures derived from embryonic (i.e., E 18.5) and postnatal rats? 
Consistent with the hypotheses, Shank colocalised with Homer1b/c in DRG 
growth cones. This finding aligns with research by Tu et al. (1999) showing 
colocalization of Shank and Homer proteins in developed neurons, but is novel in 
identifying colocalization in growth cones. Given that Homer1b/c has been shown to 




functional binding of Shank and Homer1b/c is necessary for ordinary cellular 
activity (Hayashi et al., 2009), the presence of colocalization indicates a potential 
role of Homer-Shank tetramers in embryonic axon pathfinding. For instance, 
Homer1b/c mediated signalling may involve functional binding with Shank. 
However, follow up testing (e.g., completion of growth cone turning assays with 
Shank3 knockdown) would be necessary to explore this possibility. 
Visual assessment methods of colocalization analysis have previously been 
criticised for observer bias (Costes et al., 2004). This is problematic, as I expected to 
find Homer1b/c and Shank colocalization prior to immunocytochemistry 
experiments, and likely interpreted results with confirmation bias. I recommend an 
unbiased correlational analysis of protein colocalization (as in Costes et al., 2004) to 
objectively measure the degree of association between Homer and Shank proteins 
and validate results. Alternatively, visual assessment of protein colocalization by 
multiple researchers ignorant to the hypotheses would reduce measurement bias and 
increase the internal validity of this experiment.  
There was No Significant Difference in pan-Shank immunoreactivity between 
Shank3 siRNA-treated and Wild Type Cell Cultures 
The current study failed to demonstrate knockdown of Shank3 protein in both 
the soma of DRG, and the growth cones. There are two reasons why knockdown 
may have been unsuccessful in these experiments.  
Firstly, cells were transfected with Shank3-specific siRNA, but incubated in 
pan-Shank antibody. This method has previously been used to infer Shank3 
knockdown as a decrease in overall Shank protein expression in cultures of aspiny 
cerebellar granular cells (Roussignol et al., 2005). As such, the lack of significant 




rather than an issue with the methodology. It is possible that embryonic DRGs 
express Shank1 or Shank2 isoforms, but not Shank3. This would have led to no 
difference in immunoreactivity between WT and KD cultures following Shank3 
siRNA transfection. However, this would be unexpected, given that Shank3 protein 
has previously been isolated in mature DRGs by Han et al. (2016). 
An alternative explanation is that downregulating production of the Shank3 
protein isoform led to compensatory upregulation of Shank1 or Shank2, which could 
have led to no difference in overall Shank protein expression between KD and WT 
cells stained with pan-Shank antibodies. This is feasible, as Shank2 knockout in 
mice has previously been associated with increase in synaptic Shank3 protein 
(Schmeisser et al., 2012). If Shank3 haploinsufficiency leads to compensatory 
upregulation of other Shank isoforms, this would have reduced the interpretability of 
immunocytochemistry analyses that quantified Shank3 expression with pan-Shank 
primary antibody. 
A third possible explanation is that an issue with the siRNA inhibited Shank3 
knockdown. Consistent with manufacturer instructions, Shank3 siRNA was stored at 
- 20°C, and aliquots were refrigerated for a maximum of 2 weeks once thawed 
(Thermo Fisher Scientific, 2019). If siRNA knockdown ability decreased with time 
spent in a thawed state, this would have therefore been clearly demonstrated in the 
results as a gradual, systematic increase in pan-Shank immunoreactivity across both 
treatment groups from experiment 1 to experiment 3. However, there was no 
significant main effect of time in a 2x3 ANOVA, indicating that Shank expression 
was consistent across all three experiments. 
Contrary to manufacturer guidelines (Thermo Fisher Scientific, 2019), cell 




>24 hours recommended. This procedure was necessitated as growth cones were 
prone to collapse, but  this procedure likely compromised internal validity by 
reducing the extent of Shank3 knockdown. A transfection period of 24-48 hours may 
therefore be more likely to yield significant knockdown results. However, based on 
the current dataset, it is unlikely that any growth cones would be uncollapsed after an 
incubation period of this length. 
The use of a pan-Shank primary antibody made it impossible to determine 
which Shank isoforms were expressed in the growth cone. This represents a serious 
limitation. I therefore recommend repeating Shank3 knockdown in DRGs, but 
incubating WT and Shank3 siRNA-treated cells in Shank3-specific primary antibody 
to increase result specificity. As there was no significant effect of siRNA treatment 
on protein expression in the current study, I expect that DRG growth cones do not 
express Shank3 protein. This would explain the lack of significant results in 
knockdown experiments, and allow researchers to rule out alternative explanations 
like compensatory upregulation of other Shank isoforms, or lack of knockdown due 
to insufficient transfection time.  
Limitations  
Poor cell culture growth undermined live cell imaging procedures 
It was impossible to quantify the effects of Shank3 knockdown on growth 
cone turning and extension. Both KD and WT cell cultures failed to grow sufficient 
growth cones to complete adequately-powered turning experiments, and the majority 
of growth cones observed in a follow-up immunocytochemistry protocol were 
collapsed. This result was consistent across both siRNA-treated and WT cells, 





Growth cones collapsed during the >12 hour incubation period employed 
prior to live cell imaging. In the molecular neuroscience laboratory, 
immunocytochemical and live cell imaging data has previously been obtained from 
uncollapsed DRG growth cones within 4-6 hours post-plating (see Mitchell et al., 
2012). An incubation period of this brevity was not feasible in the current 
experiment due to the transfection time required for siRNA knockdown (Thermo 
Fisher Scientific, 2019). However, examination of cell cultures during the incubation 
period revealed both siRNA-treated and WT cell cultures consistently failed to 
project axons even within 4-6 hours (data not shown). Other members of the 
laboratory did not experience similar issues with DRGs derived from the same 
animals, indicating that this issue was unique to my cultures. This indicates that I 
committed systematic errors throughout the experimental process that undermined 
the growth of both KD and WT DRGs. 
Attempts to Improve Cell Culture Growth were Unsuccessful 
When first alerted to issues with culture growth, I underwent complete 
retraining in coverslip preparation, dissection, and cell culture procedures. As many 
cultures contained bacteria, I ensured sterility by thoroughly spraying all dissection 
equipment and embryos with 70% ethanol solution prior to removing skin and spinal 
cords. This procedure successfully reduced bacterial growth, however, increases in 
DRG axonal projection were not observed.  
Systematic errors in coverslip preparation may have reduced cell growth. 
Initially, I soaked coverslips in nitric acid for a minimum of one hour, then rinsed 
coverslips five times for 25 minutes with MilliQ H2O. If rinses were insufficient to 
remove acid from coverslip glass, residual acid may have corroded cell cultures. To 




ethanol, and water to remove all acid and ensure glass sterility. This procedure 
increased the ability of SNM to form an airtight bubble over the coverslip (and thus, 
reduce exposure of plated cells to air). However, cell cultures still failed to grow 
axons and growth cones within the typical four hour period observed by other 
members of the laboratory.  
This indicates that I committed errors, likely a result of inexperience, that led 
to cell death. To address this issue, a competent member of the laboratory group 
completed the coverslip preparation, dissection, and cell culture procedures for F-
Actin-only analysis of DRGs. This allowed me to rule out inexperience at cell 
culture techniques as a factor effecting cell growth.  
However, the growth of these cultures remained minimal, as four coverslips 
yielded only 19 DRGs with axonal growth – and of these, the majority of growth 
cones were collapsed. As axonal growth and growth cone collapse were not 
dependent on treatment condition, this indicates that errors in cell culture within the 
laboratory are systematic and are likely ingrained in the procedures used. Before 
continuing knockdown experiments, it is a priority to identify and rectify reasons for 
cell culture failure.  
F-Actin immunostaining revealed that DRGs with axons were predominately 
multipolar. Clark, Britland, and Connolly (1993) demonstrated that DRGs grown 
without laminin are more likely to be multipolar, and increases in laminin 
concentration were associated with greater likelihood of bipolar cell morphology. As 
such, I propose that the lack of cell culture growth may have been caused by 
deficient laminin coating of coverslips. Increasing the amount of laminin stock in 





Strengths of the Study 
Shank3 knockdown quantification was region-specific 
Shank3 knockdown was quantified in specific areas of interest (the soma and 
growth cone) using integrated pixel density analysis. This represents an 
improvement of traditional methods for quantifying knockdown, such as Western 
Blot, that quantify protein expression in an entire tissue sample (Alberts et al., 2015). 
Cell cultures in this study contained heterogenous neuronal, glial, and blood cells, of 
which pseudo-unipolar DRGs constituted only a small fraction, and DRGs with 
uncollapsed growth cones a smaller fraction still. Western Blot would have lacked 
the specificity necessary to quantify cell-specific (and indeed, growth-cone specific) 
knockdown in these cultures. Using region-specific analysis, I demonstrated that 
there was no significant difference due to siRNA treatment on Shank protein 
expression in the soma and growth cone of DRGs, a conclusion that could not have 
been made using Western Blot. 
Knockdown results were consistent across three experiments 
In order to increase internal validity, each knockdown experiment was 
repeated a minimum of three times, using embryonic DRG cell cultures derived from 
three different animals. In a 2 x 3 ANOVA, there was no significant main effect of 
experiment number on Shank protein expression, indicating results were consistent 
across all three testing sessions. This is a positive finding, as it means findings are 
likely to be robust, and experimental error was consistent across experiments. For 
instance, prolonged exposure to light during microscopy led to photobleaching of 
secondary antibodies. As such, a potential confound could have been that 
Experiment 1 microscopy (undertaken during the learning stage, when time required 




misinterpreted as decreased protein expression indicating knockdown success. 
However, as protein expression was consistent across all experiments, this eliminates 
photobleaching as a potential confound.  
Rationalising the Choice of Statistical Analysis 
The effects of Shank3 knockdown on protein expression should have been 
analysed with mixed linear modelling (MLM), as the ANOVA assumption of 
independence was violated. Data structure was hierarchical, with cells nested 
according to coverslip (Level 1 hierarchy), embryo (Level 2 hierarchy), and 
experiment number (Level 3 hierarchy). Whilst a 2 x 3 ANOVA indicated 
experimental consistency, it is possible that lower levels of the data hierarchy (i.e., 
coverslip conditions) influenced culture growth, as the rate of axonal projection was 
highly varied across coverslips within the same experiment. Analysis with MLM 
allows modelling of random intercepts and slopes of hierarchical data (Field, 2009), 
which would have allowed for statistical validation of this observation.  
To meet the ANOVA assumption of even group sizes, data collection was 
terminated once 27 DRG images per condition were acquired. This led to data loss 
by necessity, despite meeting power requirements. Analysis with MLM would have 
accommodated for uneven group sizes (Field, 2009), allowed inclusion of the entire 
data set, and thus yielded a more representative data sample. 
However, the current literature states that the minimum group size required to 
run MLM with 80% power is 1600 observations per condition (Brysbaert & Stevens, 
2018), which equates to 3200 observations total for knockdown quantification. As it 
took me approximately an hour to acquire 20 cell images, it was determined that an 
MLM analysis requiring 160 hours of microscopy analysis alone was not realistically 




Knockdown has previously been calculated in the cellular neurobiology 
laboratory using three consecutive student’s t tests (if normally distributed) or Mann-
Whitney U tests (if not normally distributed) with alpha values for significance set 
at .05 (see Gasperini et al., 2009; Mitchell et al., 2012; Pavez et al., 2019). However, 
an issue with running multiple tests with a p value of .05 is inflation of Type I error 
(Field, 2009). As such, the choice of a 3 x 2 ANOVA for analysis of somatic 
knockdown represents an improvement of standard protocols by reducing Type I 
error rate, and is a suitable compromise given the unattainable power requirements 
of MLM. Mann-Whitney U tests and t tests were only used in cases where the power 
requirements of ANOVA were not achieved.  
Directions for Future Research 
When grown on laminin, DRGs have bipolar morphology with identifiable 
axons and growth cones (Clark et al., 1993), and well-characterised responses to 
diverse chemoattractants (e.g., Gasperini et al., 2009; Gundersen & Barrett, 1989). 
However, this project failed to quantify Shank3 knockdown in DRG growth cones 
and was unable to measure corresponding effects on growth cone motility. Future 
projects may attain greater success studying Shank3 knockdown effects in cell types 
known to express Shank3 in the growth cone, such as cultured hippocampal cells 
(Naisbitt et al., 1999).  
Glutaminergic NMDA and AMPA receptors mediate LTP in mature 
hippocampal cells (Siegelbaum & Kandel, 2013), a process disrupted by Shank3 
knockout (Bozdagi et al., 2010). As Shank3 protein is present in hippocampal 
growth cones (Naisbitt et al., 1999), future research may seek to determine whether 
Shank3 knockdown disrupts glutamate-mediated axonal pathfinding in hippocampal 




clinical significance, as abnormalities in hippocampal neural circuitry in embryo 
could potentially form the foundation for learning and memory difficulties seen in 
ID; a disorder often comorbid with ASD (American Psychological Association, 
2013). Furthermore, the use of CNS-derived hippocampal cells (as opposed to PNS-
derived DRGs) would increase generalisability of turning assay results to 
conclusions about brain development.  
Investigating this research question would require development of a new 
dissection procedure for embryonic rat hippocampal cells. In order to isolate effects 
of Shank3 knockdown on NMDAR- and AMPAR-mediated glutaminergic 
signalling, it would be necessary to inhibit IP3 signalling and resultant calcium 
release as a result of glutamate binding to mGluRs. This may be achieved by co-
transfecting hippocampal cultures with siRNA for Shank3 and mGluR1/5, in order to 
knockdown expression of both proteins prior to completing glutamate-mediated 
turning assays.  
Conclusion 
The current study demonstrates localisation of pan-Shank protein in the 
growth cone of DRGs, and appears to demonstrate growth cone colocalization with 
Homer1b/c. These findings extend and enrich our understanding of peripheral 
neurodevelopment. Specifically, the results of this study build on findings by Miletic 
et al. (2010) and Han et al. (2016) showing Shank1 and Shank3 expression in mature 
DRGs, and suggest a role of pan-Shank protein in embryonic DRG circuitry.  
This research project represents a step into exploring the role of Shank3 
protein in guiding embryonic neurodevelopment. Whilst findings were limited due to 




research is likely to yield novel results with clinical significance for understanding of 
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